U.S. stock futures were struggling early Tuesday following record highs in the previous session. S&P 500 futures were edging up less than 0.1% and Nasdaq 100 futures were down 0.1%. The S&P and Nasdaq ...
License provides Lisata’s innovative certepetide targeting agent for use with Kuva’s NanoMark™ MR imaging platform to advance non-invasive, high-precision cancer diagnosticsBASKING RIDGE, N.J. and ...